Research output per year
Research output per year
Personal profile
Related documents
Education/Academic qualification
医学博士, Chiba University
… → Mar 2016
External positions
Associate Professor, Teikyo University
Apr 2025 → …
Associate Professor, Chiba University
Apr 2024 → …
Associate Professor, Teikyo University
Apr 2024 → Mar 2025
Assistant Professor, Chiba University
Apr 2022 → Mar 2024
特任助教, Chiba University
Nov 2019 → Mar 2022
Postdoctoral researcher, University of California, San Diego, Moores Cancer Center
Apr 2017 → Nov 2019
Research Fields
- Tumor biology
- Urology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Yusuke Goto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Early Suture Thread for Port Closure in Robotic Surgery
Translated title of the contribution :Early Suture Thread for Port Closure in Robotic Surgery Research output: Contribution to journal › Article
-
Early Suture Thread for Port Closure in Robotic Surgery
Goto, Y., Matsumoto, Y., Wakai, K., Oka, R., Kato, H. & Naya, Y., May 2026, In: International Journal of Urology. 33, 5, e70503.Research output: Contribution to journal › Comment/debate
Open Access -
Editorial Comment on Beyond Total PSA: Clinical Significance of S2,3PSA% in Reducing Unnecessary Prostate Biopsies
Translated title of the contribution :Editorial Comment on Beyond Total PSA: Clinical Significance of S2,3PSA% in Reducing Unnecessary Prostate Biopsies Research output: Contribution to journal › Article
1 Scopus citations -
Editorial Comment on Comparison of Perioperative Chemotherapy Regimens for Muscle‐Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials
Translated title of the contribution :Editorial Comment on Comparison of Perioperative Chemotherapy Regimens for Muscle‐Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials Research output: Contribution to journal › Article
-
MEK1 as a Synthetic Lethal Target with Cabozantinib in Renal Cell Carcinoma: Insights from CRISPR/Cas9 Screening
Translated title of the contribution :MEK1 as a Synthetic Lethal Target with Cabozantinib in Renal Cell Carcinoma: Insights from CRISPR/Cas9 Screening Research output: Contribution to journal › Article